Lmcg Investments LLC Raises Position in Danaher Co. (NYSE:DHR)

Lmcg Investments LLC raised its holdings in shares of Danaher Co. (NYSE:DHR) by 11.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 103,988 shares of the conglomerate’s stock after acquiring an additional 10,342 shares during the quarter. Danaher makes up 1.4% of Lmcg Investments LLC’s portfolio, making the stock its 14th largest holding. Lmcg Investments LLC’s holdings in Danaher were worth $21,318,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Norges Bank purchased a new position in shares of Danaher during the 4th quarter worth $2,130,740,000. GAMMA Investing LLC lifted its stake in shares of Danaher by 24,958.2% during the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate’s stock valued at $383,524,000 after buying an additional 1,863,381 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Danaher during the 4th quarter valued at $391,172,000. Two Sigma Advisers LP lifted its stake in shares of Danaher by 4,248.8% during the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock valued at $376,347,000 after buying an additional 1,601,800 shares in the last quarter. Finally, Capital World Investors lifted its stake in shares of Danaher by 32.7% during the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock valued at $1,460,215,000 after buying an additional 1,566,658 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.6%

Shares of NYSE DHR opened at $193.21 on Thursday. The business’s 50 day moving average is $191.68 and its two-hundred day moving average is $212.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The stock has a market capitalization of $138.27 billion, a P/E ratio of 36.59, a PEG ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. As a group, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.66%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Robert W. Baird lowered their target price on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. The Goldman Sachs Group decreased their price target on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 23rd. Jefferies Financial Group decreased their price target on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. Finally, HSBC decreased their price target on shares of Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $263.24.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.